Heres your complete guide to starting telehealth weight loss treatment
If you have not had bloodwork done recently, schedule it before your GLP-1 appointment
Consumer Sentiment in 2025 Market analysts report a rise in "mixed intent" searches-people researching both reviews and complaints
Strategic supplementation fills those gaps without adding unnecessary calories
Its role in glucose homeostasis and its application in diabetes treatment
Meanwhile, Chinese companies are rapidly advancing through fast following, innovation and licensing, with key developments including Innovents mazdutide, Innogens supaglutide, Hengruis oral candidate HRS-7535, United Laboratories licensing of its first-in-class triple-G (GLP-1, gastric inhibitory polypeptide (GIP) and glucagon) a gonist to Novo Nordisk and Ascletis positive Phase 1 results for its oral + injection candidate, ASC30